ARCHIVES

Text of Peer Review Of Medenica’s Treatment Of Breast Cancer Patient

This article is from The Cancer Letter archive.

Vol. 19 No. 18 | April 30, 1993

Download PDF Visit The Full Archive

Related Articles

Congressional Report Days NCI Ignored Data, Procedure, In Changes To Screening Guidelines

November 4, 1994

Phase III Trial of Avastin and Temozolomide Shows Reduced Risk of Cancer Progression

November 30, 2012

Movement To Resolve Patient Care Reimbursement Problems Gains Momentum; NCI Report Adds Fuel

March 17, 1989

New ACS Program Honors Mary Lasker

August 31, 1984

Researchers Identify Five Genes Associated With Melanoma Risk

July 29, 2011

FDA Approves Herceptin For HER2+ Metastatic Stomach Cancers

October 22, 2010